Home » Newsletters » BioWorld Science

BioWorld Science

May 7, 2015

View Archived Issues

Baxter's Ross River virus vaccine well tolerated in phase III study

Shire updates progress of first quarter 2015

Turnstone Biologics combines oncolytic and vaccine activity in single viral vector

Antroquinonol assigned FDA orphan drug designation for acute myeloid leukemia

Lenalidomide gains another U.S. orphan drug designation

Cancer Targeted Technology receives grant to develop PET imaging agent for prostate cancer

Tobira Therapeutics completes merger with Regado Biosciences

Graspa expanded access program cleared to continue by DSMB

Acacia Pharma posts results from phase II study of APD-403 for CINV

ZIOPHARM starts phase I trial of Ad-RTS-hIL-12 plus veledimex in glioma and glioblastoma

Global Enterprises Group launches personalized medicine developer Predictive Therapeutics

Bellicum in-licenses rights to TCR therapies against two tumor antigens

Basilea's pan-RAF kinase inhibitor BAL-3833 enters phase I study

Replicor discloses phase II data for REP-2139

A novel isoquinolone sulfonamide derivative for wet AMD

NCX-667 reduces IOP in different animal models

DHA derivative confers protection against neovascularization and retinopathy

Tadalafil given orphan designation in the U.S. for Duchenne muscular dystrophy

Lokon Pharma receives U.S. orphan drug label for cancer vaccine

New phase II trial of MM-141 for pancreatic cancer in biomarker-selected patients

Kineta releases topline phase Ib results on dalazatide in plaque psoriasis

E.U. marketing submission for GSK-2696273 gene therapy to treat ADA-SCID

Roche and Genentech divulge NMDA receptor modulators

Eisai reports TLR7 and TLR8 antagonists

Janssen describes ROR-gamma-t receptor modulators

Bayer Schering Pharma develops adenosine A2B receptor antagonists

MJFF and Prothena join forces to accelerate discovery of biomarkers for Parkinson's disease

Teva completes acquisition of Auspex

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 15, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
EHA 2026: With new lenses, a changing view on pediatric cancers
BioWorld
In the most simplistic view, adult cancers occur because “immature cells are exposed to mutagens, accumulate mutations, and across life ultimately transform into...
Fortvita and Innovent patent new anti-TROP2/B7-H4 ADCs
BioWorld Science
Fortvita Biologics Inc. and Innovent Biologics (Suzhou) Co. Ltd. have jointly reported new antibody-drug conjugates (ADCs) comprising a bispecific antibody or...
Anti-C5aR1 antibodies linked to outcomes in giant cell arteritis
BioWorld Science
More effective glucocorticoid-sparing therapies are needed for the treatment of giant cell arteritis (GCA). Studies found that complement signaling pathways...